Methyl-n-amylnitrosamine (MNAN) is a potential carcinogen[1] It is metabolized in the liver by the enzyme CYP2A6.

References

  1. ^ Bulay O, Mirvish SS (September 1979). "Carcinogenesis in rat esophagus by intraperitoneal injection of different doses of methyl-n-amylnitrosamine". Cancer Res. 39 (9): 3644–6. PMID 476689.


Allikas: https://en.wikipedia.org/wiki/MNAN
No tags for this post.